Press Release
Healthcare News

Cardiac Biomarkers Market Had a Sizeable Impact in 2018 and Predicted to Achieve Double-Digit CAGR By 2023 [Get Latest Report]

Global Cardiac Biomarkers Market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the forecast period 2015-2020. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/309

Cardiac biomarkers are protein-based traceable substances used as an indicator of biological state for diagnostic and prognostic purposes associated with cardiac conditions. Commercialization of highly advanced and accurate type of cardiac biomarkers has provided a novel platform for diagnosis of cardiac diseases. Continuous focus on pipeline research and developments from leading players and increased patient awareness across untapped regions such as India, China is largely driving the growth of cardiac biomarkers market.

The growing application of cardiac biomarkers as point of care (POC) testing facilitate quick results in chronic conditions, thus drives the market growth. However, specificity and sensitivity related concerns of single measurement cardiac biomarkers, premium pricing and certain government regulations would hinder the market growth. Also, the overall market growth would bank on novel progress made in cardiac treatments using multi-assay biomarkers. The life saving benefits of these multi-assay biomarkers would foster the revenue generation process as well as market penetration of novel cardiac biomarkers in the future.

Key findings of Cardiac Biomarkers Market:
• Troponin segment is projected as a leading market segment throughout the forecast period
• Revenue of myocardial infarction application segment is expected to grow almost threefold by 2020
• Laboratory location of testing market segment still dominates the global market
• Point of care location of testing segment is projected to grow at a CAGR of 22% during the forecast period
• Countries like India and China holds prominent potential owing to higher count of undiagnosed cardiac patients

North America would continue to lead the market owing to high awareness, and favorable healthcare reimbursement policies. In addition, Asia Pacific would emerge as one of the most lucrative regions and would closely follow Europe in terms of revenue. Prime factor fueling the growth of Asia Pacific region includes, presence of a large number of undiagnosed cardiac patients, rapid urbanization, rising disposable income, and growing awareness about cardiac disease management programs i.e. Quick cardiac checkup (QCC).

The principal strategy adopted by the leading players in the market is the product launch. The key companies profiled in the report are Abbott laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation, Beckman Coulter, Becton, Dickinson and Company, Thermo Fisher Scientific, BioMerieux, Bio-Rad Laboratories and Randox laboratories.

Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/309

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key Benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Biomarker diagnosis vs. conventional diagnosis
3.3 Assessment of key advantages and buying criteria for diagnostic biomarkers
3.3.1 Early diagnosis
3.3.2 Tissue specific diagnosis
3.3.3 Reduce clinical trials
3.3.4 Risk assessments
3.3.5 Consistent output
3.4 Key trends impacting the Cardiac biomarkers market
3.4.1 Development of high sensitive biomarkers for risk stratification
3.4.2 Technological advancements in the cardiac biomarkers: Serum based biomarkers
3.4.3 Increasing demand for point of care cardiac diagnostics
3.5 Key Findings
3.5.1 Top Factors Impacting
3.5.2 Top Investment Pockets
3.5.3 Top winning strategies
3.6 Government Regulations and reimbursement
3.7 Reimbursement scenario
3.8 Porters five force Analysis
3.8.1 Bargaining power of suppliers
3.8.2 Bargaining power of buyers
3.8.3 Threats from substitute products
3.8.4 Threat from new entrants
3.8.5 Industry rivalry
3.9 Value chain analysis
3.10 Clinical Trials
3.11 Patent Analysis
3.12 Market Share Analysis, 2014
3.13 Market Dynamics
3.13.1 Drivers
3.13.1.1 Increasing prevalence of cardiovascular diseases
3.13.1.2 Cost effective
3.13.1.3 Non-invasive
3.13.1.4 Accuracy prediction
3.13.1.5 Assistant in clinical trials
3.13.1.6 Multi-marker application
3.13.1.7 Technological advancements using cardiac biomarkers combinations
3.13.1.8 Increasing point of care (POC) testing
3.13.2 Restraints
3.13.2.1 Government Regulation
3.13.2.2 Conformation in result
3.13.2.3 Complex process
3.13.3 Opportunities
3.13.3.1 Personalized medicine
3.13.3.2 Point of care (POCT) testing using cardiac biomarkers
3.13.3.3 Future DEVELOPMENTS IN novel cardiac biomarkers

Access Full Summery @ https://www.alliedmarketresearch.com/cardiac-biomarkers-market

About the author

Allied Market Research

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Call Us
( U.S. - Canada toll free )
+1-800-792-5285, Int'l : +1-503-894-6022

Drop us an email at
[email protected]

Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.